XML 63 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Numerator:    
Net loss from continuing operations, net of tax $ (5,982) $ (100,018)
Net loss attributable to noncontrolling interests — continuing operations 1,412 20,360
Net loss attributable to Bioventus Inc. Class A common stockholders — continuing operations (4,570) (79,658)
Net loss from discontinued operations, net of tax 0 (74,429)
Net loss attributable to noncontrolling interests — discontinued operations 0 14,937
Net loss attributable to Bioventus Inc. Class A common stockholders — discontinued operations $ 0 $ (59,492)
Denominator:    
Weighted-average shares of Class A common stock outstanding - basic (in shares) 63,380,187 62,124,752
Weighted-average shares of Class A common stock outstanding - diluted (in shares) 63,380,187 62,124,752
Net loss per share of Class A common stock from continuing operations, basic (in dollars per share) $ (0.07) $ (1.28)
Net loss per share of Class A common stock from continuing operations, diluted (in dollars per share) (0.07) (1.28)
Net loss per share of Class A common stock from discontinuing operations, diluted (in dollars per share) 0 (0.96)
Net loss per share of Class A common stock from discontinuing operations, basic (in dollars per share) 0 (0.96)
Net loss per share of class A common stock, basic (in dollars per share) (0.07) (2.24)
Net loss per share of class A common stock, diluted (in dollars per share) $ (0.07) $ (2.24)